Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-02-01 @ 5:11 PM
Study NCT ID:
NCT02603705
Status:
COMPLETED
Last Update Posted:
2018-03-05
First Post:
2015-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D059350', 'term': 'Chronic Pain'}], 'ancestors': [{'id': 'D010146', 'term': 'Pain'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 281}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2016-03-07', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-03', 'completionDateStruct': {'date': '2017-06-15', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-03-02', 'studyFirstSubmitDate': '2015-11-10', 'studyFirstSubmitQcDate': '2015-11-10', 'lastUpdatePostDateStruct': {'date': '2018-03-05', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2015-11-13', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2017-06-15', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Incidence of TEAEs during the Open-label Treatment Period, including those leading to treatment withdrawal, and/or abnormal physical examination findings, vital signs measurements, ECGs, and clinical laboratory test results, related to treatment', 'timeFrame': '1 year'}], 'secondaryOutcomes': [{'measure': 'Findings of the Brief Pain Inventory-Short Form (BPI-SF) during the Open-label Treatment Period', 'timeFrame': '1 year'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['chronic pain', 'opioid', 'oxycodone', 'non cancer pain', 'moderate to severe'], 'conditions': ['Moderate-to-severe Chronic Noncancer Pain']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to evaluate the safety and tolerability of Egalet-002 in opioid-experienced patients with moderate-to-severe chronic noncancer pain.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '75 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Is a man or woman between 18 and 75 years of age.\n* Has a clinical history of moderate-to-severe chronic noncancer pain ≥6 months.\n* Has required opioid therapy for at least 14 days prior to Screening at a dose between 20 mg and 160 mg (inclusive) oxycodone/day (or opioid equivalent), and will, in the opinion of the investigator, continue to require opioid therapy (between 20 mg and 240 mg oxycodone/day, inclusive) for management of moderate-to-severe pain for the duration of the study.\n* Has pain either not adequately controlled on current opioid regimen, requires a change of opioid due to tolerability of current opioid regimen or in the opinion of the investigator, would benefit from changing opioid for another reason.\n* Has stable health, as determined by the investigator.\n* If female, the patient is currently not pregnant, not breast-feeding, nor attempting to become pregnant (for 30 days before screening through the duration of the study), or is of non-childbearing potential.\n* Other Criteria Apply\n\nExclusion Criteria:\n\n* Has cancer-related pain.\n* Is receiving \\>240 mg oxycodone daily (or opioid equivalent) within 30 days before Screening.\n* Has a history of attempted suicide.\n* Has used a spinal infusion pump within 6 months before Screening.\n* Has clinically unstable cardiac disease (including atrial fibrillation, symptomatic bradycardia, unstable congestive heart failure, or active myocardial ischemia) and/or respiratory disease (including chronic obstructive pulmonary disease or sleep apnea).\n* Has positive urine toxicity screen for drugs of abuse (with the exception of prescribed medications).\n* Has positive result for tetrahydrocannabinol (even if legally prescribed).\n* Has current (or history of within the last 12 months) drug dependence or substance abuse disorder according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision criteria (excluding nicotine).\n* Other Criteria Apply'}, 'identificationModule': {'nctId': 'NCT02603705', 'briefTitle': 'Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain', 'organization': {'class': 'INDUSTRY', 'fullName': 'Egalet Ltd'}, 'officialTitle': 'An Open-label Phase 3 Trial to Evaluate the Safety and Tolerability of Egalet ADER Oxycodone Tablet, Egalet-002, in Patients With Moderate-to-Severe Chronic Noncancer Pain', 'orgStudyIdInfo': {'id': 'OC-EG-303'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Oxycodone extended-release', 'description': 'Egalet abuse-deterrent, extended-release oxycodone tablet', 'interventionNames': ['Drug: Oxycodone extended-release']}], 'interventions': [{'name': 'Oxycodone extended-release', 'type': 'DRUG', 'armGroupLabels': ['Oxycodone extended-release']}]}, 'contactsLocationsModule': {'locations': [{'zip': '35801', 'city': 'Huntsville', 'state': 'Alabama', 'country': 'United States', 'facility': 'Site 334', 'geoPoint': {'lat': 34.7304, 'lon': -86.58594}}, {'zip': '85712', 'city': 'Tucson', 'state': 'Arizona', 'country': 'United States', 'facility': 'Site 328', 'geoPoint': {'lat': 32.22174, 'lon': -110.92648}}, {'zip': '32257', 'city': 'Jacksonville', 'state': 'Florida', 'country': 'United States', 'facility': 'Site 332', 'geoPoint': {'lat': 30.33218, 'lon': -81.65565}}, {'zip': '33169', 'city': 'Miami Gardens', 'state': 'Florida', 'country': 'United States', 'facility': 'Site 340', 'geoPoint': {'lat': 25.94204, 'lon': -80.2456}}, {'zip': '33317', 'city': 'Plantation', 'state': 'Florida', 'country': 'United States', 'facility': 'Site 320', 'geoPoint': {'lat': 26.13421, 'lon': -80.23184}}, {'zip': '33603', 'city': 'Tampa', 'state': 'Florida', 'country': 'United States', 'facility': 'Site 302', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '33613', 'city': 'Tampa', 'state': 'Florida', 'country': 'United States', 'facility': 'Site 315', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '33880', 'city': 'Winter Haven', 'state': 'Florida', 'country': 'United States', 'facility': 'Site 310', 'geoPoint': {'lat': 28.02224, 'lon': -81.73286}}, {'zip': '30534', 'city': 'Dawsonville', 'state': 'Georgia', 'country': 'United States', 'facility': 'Site 316', 'geoPoint': {'lat': 34.42121, 'lon': -84.11908}}, {'zip': '30060', 'city': 'Marietta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Site 311', 'geoPoint': {'lat': 33.9526, 'lon': -84.54993}}, {'zip': '61701', 'city': 'Bloomington', 'state': 'Illinois', 'country': 'United States', 'facility': 'Site 336', 'geoPoint': {'lat': 40.4842, 'lon': -88.99369}}, {'zip': '60406', 'city': 'Blue Island', 'state': 'Illinois', 'country': 'United States', 'facility': 'Site 345', 'geoPoint': {'lat': 41.65726, 'lon': -87.68005}}, {'zip': '47714', 'city': 'Evansville', 'state': 'Indiana', 'country': 'United States', 'facility': 'Site 304', 'geoPoint': {'lat': 37.97476, 'lon': -87.55585}}, {'zip': '46383', 'city': 'Valparaiso', 'state': 'Indiana', 'country': 'United States', 'facility': 'Site 325', 'geoPoint': {'lat': 41.47309, 'lon': -87.06114}}, {'zip': '66210', 'city': 'Overland Park', 'state': 'Kansas', 'country': 'United States', 'facility': 'Site 321', 'geoPoint': {'lat': 38.98223, 'lon': -94.67079}}, {'zip': '67205', 'city': 'Wichita', 'state': 'Kansas', 'country': 'United States', 'facility': 'Site 342', 'geoPoint': {'lat': 37.69224, 'lon': -97.33754}}, {'zip': '70114', 'city': 'New Orleans', 'state': 'Louisiana', 'country': 'United States', 'facility': 'Site 329', 'geoPoint': {'lat': 29.95465, 'lon': -90.07507}}, {'zip': '02169', 'city': 'Quincy', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Site 326', 'geoPoint': {'lat': 42.25288, 'lon': -71.00227}}, {'zip': '63141', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Site 303', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '89119', 'city': 'Las Vegas', 'state': 'Nevada', 'country': 'United States', 'facility': 'Site 306', 'geoPoint': {'lat': 36.17497, 'lon': -115.13722}}, {'zip': '07823', 'city': 'Belvidere', 'state': 'New Jersey', 'country': 'United States', 'facility': 'Site 313', 'geoPoint': {'lat': 40.82982, 'lon': -75.07767}}, {'zip': '08012', 'city': 'Blackwood', 'state': 'New Jersey', 'country': 'United States', 'facility': 'Site 346', 'geoPoint': {'lat': 39.80234, 'lon': -75.06406}}, {'zip': '10530', 'city': 'Hartsdale', 'state': 'New York', 'country': 'United States', 'facility': 'Site 323', 'geoPoint': {'lat': 41.01899, 'lon': -73.79819}}, {'zip': '28117', 'city': 'Mooresville', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Site 338', 'geoPoint': {'lat': 35.58486, 'lon': -80.81007}}, {'zip': '45212', 'city': 'Cincinnati', 'state': 'Ohio', 'country': 'United States', 'facility': 'Site 333', 'geoPoint': {'lat': 39.12711, 'lon': -84.51439}}, {'zip': '44122', 'city': 'Cleveland', 'state': 'Ohio', 'country': 'United States', 'facility': 'Site 343', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'zip': '45424', 'city': 'Huber Heights', 'state': 'Ohio', 'country': 'United States', 'facility': 'Site 308', 'geoPoint': {'lat': 39.84395, 'lon': -84.12466}}, {'zip': '45429', 'city': 'Kettering', 'state': 'Ohio', 'country': 'United States', 'facility': 'Site 347', 'geoPoint': {'lat': 39.6895, 'lon': -84.16883}}, {'zip': '73112', 'city': 'Oklahoma City', 'state': 'Oklahoma', 'country': 'United States', 'facility': 'Site 335', 'geoPoint': {'lat': 35.46756, 'lon': -97.51643}}, {'zip': '97401', 'city': 'Eugene', 'state': 'Oregon', 'country': 'United States', 'facility': 'Site 312', 'geoPoint': {'lat': 44.05207, 'lon': -123.08675}}, {'zip': '16635', 'city': 'Duncansville', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Site 322', 'geoPoint': {'lat': 40.42341, 'lon': -78.4339}}, {'zip': '19610', 'city': 'Wyomissing', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Site 324', 'geoPoint': {'lat': 40.32954, 'lon': -75.96521}}, {'zip': '29588', 'city': 'Myrtle Beach', 'state': 'South Carolina', 'country': 'United States', 'facility': 'Site 344', 'geoPoint': {'lat': 33.68906, 'lon': -78.88669}}, {'zip': '29485', 'city': 'Summerville', 'state': 'South Carolina', 'country': 'United States', 'facility': 'Site 314', 'geoPoint': {'lat': 33.0185, 'lon': -80.17565}}, {'zip': '37825', 'city': 'New Tazewell', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Site 341', 'geoPoint': {'lat': 36.44258, 'lon': -83.59963}}, {'zip': '78731', 'city': 'Austin', 'state': 'Texas', 'country': 'United States', 'facility': 'Site 318', 'geoPoint': {'lat': 30.26715, 'lon': -97.74306}}, {'zip': '75231', 'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'Site 330', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '78218', 'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'Site 309', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '84088', 'city': 'West Jordan', 'state': 'Utah', 'country': 'United States', 'facility': 'Site 331', 'geoPoint': {'lat': 40.60967, 'lon': -111.9391}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Egalet Ltd', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}